Gilead Sciences has entered into a definitive agreement to acquire Tubulis, a private Germany-based, clinical-stage biotechnology company EQT Life Sciences led the Series B2 financing of Tubulis in March 2024, and has since suppEQTorted the Company at board level in its growth to a leading global clinical-stage ADC company AMSTERDAM, April 7, 2026 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the LSP 7 fund ("EQT Life Sciences") has exited its minority stake in Tubulis (the "Company"), a Germany-based, clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), through a sale to Gilead Sciences [Nasdaq: GILD]. Tubulis' lead asset, TUB-040, a NaPi2b-directed topoisomerase-I inhibitor (TOPO1i) ADC, is currently in Phase 1b/2 development for platinum-resistant ovarian cancer and non-small cell lung cancer (NSCLC).

Q1 2026 was an exceptional quarter for energy stocks thanks to war in the Middle East, but Q2 2026 is not guaranteed to step in its footsteps. Energy prices can go higher and push the sector higher, but they do not have to if the U.S. can neutralize Iran's ability to project force. While energy stocks are benefiting from the fighting in the short term, it may actually come back to hurt them in the long run.

Independence Bank of Kentucky bought a new position in shares of EQT Corporation (NYSE: EQT) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 14,922 shares of the oil and gas producer's stock, valued at approximately $800,000. Several other hedge

Shares of EQT Corporation (NYSE: EQT - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the twenty-seven research firms that are presently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating

The biggest names in energy and technology are all in the same room this week—and the conversation isn't about oil prices. It's about electricity.

Nike, Inc., Sysco Corporation and Boston Scientific Corporation led last week's large-cap losers as earnings, guidance and downgrades pressured stocks in a shortened trading week.

Permian Resources (NYSE: PR - Get Free Report) and EQT (NYSE: EQT - Get Free Report) are both large-cap energy companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, institutional ownership, risk and analyst recommendations. Analyst Ratings This is a summary of current

PITTSBURGH, April 2, 2026 /PRNewswire/ -- EQT Corporation (NYSE: EQT) plans to issue its first quarter 2026 financial and operating results news release after market close on Tuesday, April 21, 2026, and will host a conference call to review the results and other relevant matters on Wednesday, April 22, 2026, beginning at 10:00 a.m. ET. A brief Q&A session for securities analysts will immediately follow the discussion.

EQT (EQT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

EQT gains from rising gas prices and LNG demand, with midstream assets providing stable fee-based cash flow to offset commodity price volatility.